ResearchSafe

Reconstitution volume question for GH peptides

Posted by busy_mom in Beginner Questions - 11 points, 6 comments.

I have a pharmacology background so the math is clear in theory but the practical side still makes me pause. Say a vial contains 5 mg of peptide and I add 2 ml of bacteriostatic water. 5 mg per ml or 2500 mcg per ml.

If I want a 250 mcg dose I draw to the 10 unit mark on an insulin syringe. That part feels straightforward. Where I get stuck is when people talk about reconstituting to 1 mg per ml or using 1 ml water per 1 mg peptide.

Is that just a Convention to make dosing easier or does the actual concentration affect Stability or degradation? I have seen protocols that say use 1 ml for a 2 mg vial and others that say use 2 ml for the same vial. The final dose is the same if you adjust the draw volume so why does the starting concentration matter?

Also when a protocol says 100 mcg three times daily is that based on half-life data or just Tradition? For GH peptides with a short half-life it makes sense but I want to understand the Reasoning not just follow a template. Would appreciate any clarification.

Comments

  • biohacker_sarah: Concentration mainly affects convenience and shelf life; a higher concentration means you need less volume per dose, but the reconstituted solution can degrade more quickly. I usually prepare GH peptides at 1 mg/mL because the math is simpler and there’s less water activity, which also seems to reduce clumping. The half‑life of the peptides dictates how often you need to dose-GHRP and modified GRF require multiple injections per day, while CJC‑1295 without DAC has a longer half‑life, so some peo
  • busy_mom: That tracks with what I have seen in stability studies, water activity definitely accelerates hydrolysis and aggregation, especially at higher peptide concentrations where you get more molecular crowding. The clumping observation is interesting, I have noticed the same with higher concentration vials after a week or two in the fridge. On the dosing frequency, do you know if anyone has actually measured GH pulse amplitude comparing three times daily versus twice daily for the GHRP-2 plus Mod GRF
  • amber464: yeah the crowding thing matches what ive seen in my fridge, higher conc vials get cloudy faster for sure. on the pulse question ive only got my own hrV and igf-1 trends running ghrp-2 mod grf 3x vs 2x daily. 3x felt smoother on hrV recovery but igf-1 didnt budge much either way. small n though. you tracking anything specific?
  • busy_mom: The cloudiness observation is useful, I had not considered physical stability as a variable. I am tracking HRV and sleep architecture via Oura but not IGF-1 since that requires blood draws I have not scheduled yet. Your 3x versus 2x HRV data is interesting. Did you keep total daily dose identical or just frequency? Also what was your GHRP-2 to Mod GRF ratio?
  • nate_g: Yeah, that matches my impression too. For me the 1 mg/mL thing is mostly just easier maths and less fiddly on the syringe, not some magic concentration. I have also seen some vials look a bit less cloudy when mixed more sensibly, tbh, but that could just be handling and not the concentration itself.
  • busy_mom: Yes, that was my impression as well. The cloudiness point is interesting, actually, because I have seen the same with one vial that was mixed a bit too aggressively, so I suspect handling mattered more than the exact concentration. For me the practical reason is mainly syringe accuracy, especially when the dose is small. I am still not seeing good evidence that 1 mg/mL itself is inherently more stable, unless the buffer or storage conditions are different. If you have a paper or even a decent d

Community discussion - research and educational context only. Not medical advice.